Latest Insider Transactions at Ardent Health Partners, Inc. (ARDT)
This section provides a real-time view of insider transactions for Ardent Health Partners, Inc. (ARDT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Ardent Health Partners, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Ardent Health Partners, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 02
2025
|
Robert De Michiei Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,073
+50.0%
|
-
|
|
Apr 01
2025
|
Dave Caspers Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,768
+48.17%
|
-
|
|
Apr 01
2025
|
Dave Caspers Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,480
-32.16%
|
$29,760
$12.97 P/Share
|
|
Apr 01
2025
|
Ethan Chernin President of Health Services |
BUY
Grant, award, or other acquisition
|
Direct |
20,914
+36.75%
|
-
|
|
Apr 01
2025
|
David Raynor Byers SVP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,565
+9.34%
|
-
|
|
Apr 01
2025
|
David Schultz President Hospital Operations |
BUY
Grant, award, or other acquisition
|
Direct |
26,985
+29.6%
|
-
|
|
Apr 01
2025
|
Alfred Lumsdaine Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,971
+20.1%
|
-
|
|
Apr 01
2025
|
Stephen C. Petrovich EVP, GC and Asst. Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
22,263
+3.0%
|
-
|
|
Apr 01
2025
|
Martin Bonick President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
134,927
+10.69%
|
-
|
|
Mar 31
2025
|
Ethan Chernin President of Health Services |
SELL
Payment of exercise price or tax liability
|
Direct |
1,332
-8.12%
|
$17,316
$13.75 P/Share
|
|
Mar 31
2025
|
David Raynor Byers SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
676
-0.67%
|
$8,788
$13.75 P/Share
|
|
Mar 31
2025
|
David Schultz President Hospital Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,825
-4.68%
|
$23,725
$13.75 P/Share
|
|
Mar 31
2025
|
Alfred Lumsdaine Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,510
-1.54%
|
$32,630
$13.75 P/Share
|
|
Mar 31
2025
|
Stephen C. Petrovich EVP, GC and Asst. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,428
-0.2%
|
$18,564
$13.75 P/Share
|
|
Mar 31
2025
|
Martin Bonick President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,970
-1.29%
|
$168,610
$13.75 P/Share
|
|
Mar 21
2025
|
Peter C B Bynoe Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,916
+11.32%
|
-
|
|
Mar 21
2025
|
Suzanne Campion Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,916
+22.7%
|
-
|
|
Mar 21
2025
|
Ellen Havdala Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,916
+11.32%
|
-
|
|
Mar 21
2025
|
William M Goodyear Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,916
+11.32%
|
-
|
|
Mar 21
2025
|
Mark R Sotir Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,916
+34.54%
|
-
|
|
Mar 21
2025
|
Rahul Sen Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,916
+34.54%
|
-
|
|
Mar 21
2025
|
Edmondo Robinson Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,916
+22.7%
|
-
|
|
Mar 21
2025
|
Robert Thomas Webb Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,916
+16.8%
|
-
|
|
Dec 12
2024
|
Edmondo Robinson Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,793
+25.78%
|
-
|
|
Dec 12
2024
|
Robert Thomas Webb Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,793
+17.45%
|
-
|
|
Dec 12
2024
|
Peter C B Bynoe Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,793
+10.9%
|
-
|
|
Dec 12
2024
|
Ellen Havdala Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,793
+10.9%
|
-
|
|
Dec 12
2024
|
William M Goodyear Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,793
+10.9%
|
-
|
|
Dec 12
2024
|
Suzanne Campion Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,793
+25.78%
|
-
|
|
Nov 08
2024
|
Robert Thomas Webb Director |
BUY
Open market or private purchase
|
Direct |
20,000
+22.36%
|
$320,000
$16.98 P/Share
|
|
Sep 25
2024
|
Alfred Lumsdaine Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,742
+20.38%
|
-
|
|
Sep 25
2024
|
Stephen C. Petrovich EVP, GC and Asst. Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
9,699
+1.37%
|
-
|
|
Sep 25
2024
|
David Raynor Byers SVP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,447
+5.98%
|
-
|
|
Sep 25
2024
|
David Schultz President Hospital Operations |
BUY
Grant, award, or other acquisition
|
Direct |
16,535
+29.77%
|
-
|
|
Jul 18
2024
|
Martin Bonick President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
98,881
+8.96%
|
-
|
|
Jul 18
2024
|
David Raynor Byers SVP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,329
+8.06%
|
-
|
|
Jul 18
2024
|
Ethan Chernin President of Health Services |
BUY
Grant, award, or other acquisition
|
Direct |
16,406
+50.0%
|
-
|
|
Jul 18
2024
|
Alfred Lumsdaine Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,922
+20.31%
|
-
|
|
Jul 18
2024
|
David Schultz President Hospital Operations |
BUY
Grant, award, or other acquisition
|
Direct |
22,477
+50.0%
|
-
|
|
Jul 18
2024
|
Peter C B Bynoe Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,562
+12.99%
|
-
|
|
Jul 18
2024
|
Suzanne Campion Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,562
+36.32%
|
-
|
|
Jul 18
2024
|
William M Goodyear Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,562
+12.99%
|
-
|
|
Jul 18
2024
|
Ellen Havdala Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,562
+12.99%
|
-
|
|
Jul 18
2024
|
Edmondo Robinson Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,562
+36.32%
|
-
|
|
Jul 18
2024
|
Rahul Sen Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,562
+50.0%
|
-
|
|
Jul 18
2024
|
Mark R Sotir Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,562
+50.0%
|
-
|
|
Jul 18
2024
|
Robert Thomas Webb Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,562
+36.32%
|
-
|
|
Jul 18
2024
|
Stephen C. Petrovich EVP, GC and Asst. Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
17,584
+2.49%
|
-
|